Inflammation induced by inhaled lipopolysaccharide depends on particle size in healthy volunteers. (28th July 2016)
- Record Type:
- Journal Article
- Title:
- Inflammation induced by inhaled lipopolysaccharide depends on particle size in healthy volunteers. (28th July 2016)
- Main Title:
- Inflammation induced by inhaled lipopolysaccharide depends on particle size in healthy volunteers
- Authors:
- Doyen, Virginie
Pilcer, Gabrielle
Dinh, Phong Huy Duc
Corazza, Francis
Bernard, Alfred
Bergmann, Pierre
Lefevre, Nicolas
Amighi, Karim
Michel, Olivier - Abstract:
- Abstract : Aims: In drug development, the anti‐inflammatory properties of new molecules in the lung are currently tested using the inhaled lipopolysaccharide (LPS) model. The total and regional lung bioavailability of inhaled particles depends significantly on their size. The objective of the present study was to compare inflammatory responses in healthy volunteers after the inhalation of LPS of varying droplet size. Methods: Three nebulizers were characterized by different droplet size distributions [mean mass median aerodynamic diameters: Microcirrus (2.0 μm), MB2 (3.2 μm) and Pari (7.9 μm)]. Participants inhaled three boluses of a 20 μg (technetium 99 m‐labelled) solution of LPS, randomly delivered by each nebulizer. We measured the lung deposition of the nebulized LPS by gamma‐scintigraphy, while blood and sputum biomarkers were evaluated before and after challenges. Results: MB2 and Pari achieved greater lung deposition than Microcirrus [171.5 (±72.9) and 217.6 (±97.8) counts pixel –1, respectively, vs. 67.9 (±20.6) counts pixel –1 ; P < 0.01]. MB2 and Pari caused higher levels of blood C‐reactive protein and more total cells and neutrophils in sputum compared with Microcirrus ( P < 0.05). C‐reactive protein levels correlated positively with lung deposition ( P < 0.01). Conclusions: Inhalation of large droplets of LPS gave rise to greater lung deposition and induced a more pronounced systemic and bronchial inflammatory response than small droplets. The systemicAbstract : Aims: In drug development, the anti‐inflammatory properties of new molecules in the lung are currently tested using the inhaled lipopolysaccharide (LPS) model. The total and regional lung bioavailability of inhaled particles depends significantly on their size. The objective of the present study was to compare inflammatory responses in healthy volunteers after the inhalation of LPS of varying droplet size. Methods: Three nebulizers were characterized by different droplet size distributions [mean mass median aerodynamic diameters: Microcirrus (2.0 μm), MB2 (3.2 μm) and Pari (7.9 μm)]. Participants inhaled three boluses of a 20 μg (technetium 99 m‐labelled) solution of LPS, randomly delivered by each nebulizer. We measured the lung deposition of the nebulized LPS by gamma‐scintigraphy, while blood and sputum biomarkers were evaluated before and after challenges. Results: MB2 and Pari achieved greater lung deposition than Microcirrus [171.5 (±72.9) and 217.6 (±97.8) counts pixel –1, respectively, vs. 67.9 (±20.6) counts pixel –1 ; P < 0.01]. MB2 and Pari caused higher levels of blood C‐reactive protein and more total cells and neutrophils in sputum compared with Microcirrus ( P < 0.05). C‐reactive protein levels correlated positively with lung deposition ( P < 0.01). Conclusions: Inhalation of large droplets of LPS gave rise to greater lung deposition and induced a more pronounced systemic and bronchial inflammatory response than small droplets. The systemic inflammatory response correlated with lung deposition. NCT01081392. … (more)
- Is Part Of:
- British journal of clinical pharmacology. Volume 82:Number 5(2016:Nov.)
- Journal:
- British journal of clinical pharmacology
- Issue:
- Volume 82:Number 5(2016:Nov.)
- Issue Display:
- Volume 82, Issue 5 (2016)
- Year:
- 2016
- Volume:
- 82
- Issue:
- 5
- Issue Sort Value:
- 2016-0082-0005-0000
- Page Start:
- 1371
- Page End:
- 1381
- Publication Date:
- 2016-07-28
- Subjects:
- asthma -- endotoxin -- inflammation -- lung deposition -- particle size
Pharmacology -- Periodicals
Drugs -- Periodicals
615.1 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2125 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/bcp.13052 ↗
- Languages:
- English
- ISSNs:
- 0306-5251
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2307.180000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 11131.xml